Cargando…
Biotechnology of blood /
Biotechnology of Blood presents research on applications of biotechnology to blood and its components. The book is organized into four parts. Part I begins with an overview of the blood business in order to provide background of the industry, to identify problems, and perhaps some solutions that rel...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Boston :
Butterworth-Heinemann,
[1991]
|
| Colección: | Biotechnology series ;
19. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn894117228 | ||
| 003 | OCoLC | ||
| 005 | 20231120111850.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 141031s1991 maua ob 001 0 eng d | ||
| 040 | |a OPELS |b eng |e rda |e pn |c OPELS |d N$T |d OCLCF |d YDXCP |d OCLCQ |d OCLCO |d STF |d UKAHL |d VT2 |d OCLCO |d VLY |d OCLCQ |d S2H |d OCLCO |d OCLCQ | ||
| 019 | |a 1156359507 |a 1162579002 |a 1175722190 | ||
| 020 | |a 0750691204 |q (electronic bk.) | ||
| 020 | |a 9780750691208 |q (electronic bk.) | ||
| 020 | |a 9781483294469 |q (electronic bk.) | ||
| 020 | |a 1483294463 |q (electronic bk.) | ||
| 035 | |a (OCoLC)894117228 |z (OCoLC)1156359507 |z (OCoLC)1162579002 |z (OCoLC)1175722190 | ||
| 050 | 4 | |a TP248.65.B56 |b B56 1991eb | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 082 | 0 | 4 | |a 615/.39 |2 23 |
| 245 | 0 | 0 | |a Biotechnology of blood / |c edited by Jack Goldstein, Cell Biochemistry Laboratory, the New York Blood Center, New York, New York. |
| 264 | 1 | |a Boston : |b Butterworth-Heinemann, |c [1991] | |
| 264 | 4 | |c �1991 | |
| 300 | |a 1 online resource (viii, 463 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Biotechnology Series ; |v 19 | |
| 588 | 0 | |a Print version record. | |
| 504 | |a Includes bibliographical references and index. | ||
| 520 | |a Biotechnology of Blood presents research on applications of biotechnology to blood and its components. The book is organized into four parts. Part I begins with an overview of the blood business in order to provide background of the industry, to identify problems, and perhaps some solutions that rely on the scientific advances made possible by biotechnology. This is followed by studies on the storage and preservation of red blood cells; autologous blood salvage procedures; the development procedures to provide a constant supply of blood group O; and the development of blood substitutes. Part II on plasma fractions includes studies on the preparation of plasma fractions, recombinant antihemophilic factors, and fibrinogen. Part III on the regulation of blood cell products includes studies such as hematopoietic stem cell processing and storage; and long-term bone marrow cell cultures. Part IV on blood-borne diseases examines the inactivation of viruses found with plasma proteins and viruses found with cellular components. | ||
| 505 | 0 | |a Front Cover; Biotechnology of Blood; Copyright Page; Table of Contents; PART I: OXYGEN DELIVERY SYSTEMS; Chapter 1. Biotechnology, Economies, and the Business of Blood; 1.1 Cellular Components and Biotechnology; 1.2 Plasma Products; References; Chapter 2. Long-Term Storage and Preservation of Red Blood Cells; 2.1 Current State of Liquid Preservation at 4�C; 2.2 Current Research in Nonfrozen Systems; 2.3 Frozen Red Cells; 2.4 Post-Thaw Preservation of Red Cells; 2.5 Conclusions; References; Chapter 3. Autologous Blood Salvage Procedures; 3.1 Advantages of Autologous Transfusion | |
| 505 | 8 | |a 3.2 Clinical Applications3.3 Contraindications; 3.4 Intraoperative Blood Salvage Devices; 3.5 Postoperative Blood Salvage; 3.6 Complications; 3.7 Characteristics of Salvaged Blood; 3.8 Administrative Considerations; 3.9 Summary; References; Chapter 4. The Production of Group O Cells; 4.1 Biochemistry, Genetics, and Formation of the ABO Blood Group Antigens; 4.2 Treatment Conditions Compatible with RBC Viability; 4.3 Enzymatic Conversion of Group B RBC to Group O: In Vivo Studies; 4.4 Enzymatic Conversion of Group A RBC to Group O: In Vitro Studies; 4.5 Future Perspectives: Rh Modification | |
| 505 | 8 | |a 7.1 History of Perfluorochemicals in Oxygen Transport7.2 Data on the Use of PFC Emulsions; 7.3 Medical Applications and Clinical Studies; 7.4 Future Perfluorochemical Products; 7.5 Conclusion; References; PART II: PLASMA FRACTIONS; Chapter 8. Current Approaches to the Preparation of Plasma Fractions; 8.1 Albumin; 8.2 Plasma Protein Fraction; 8.3 Antihemophilic Factor (Factor VIII, or AHF); 8.4 Immunoglobulins; 8.5 Fibrinogen; 8.6 Prothrombin Complex; 8.7 Activated Prothrombin Complex Concentrates; 8.8 Antithrombin III; 8.9 Current Equipment and Technologies Used in Plasma Fractionation | |
| 546 | |a English. | ||
| 650 | 0 | |a Blood products |x Biotechnology. | |
| 650 | 6 | |a Produits sanguins |0 (CaQQLa)201-0186213 |x Biotechnologie. |0 (CaQQLa)201-0378829 | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Blood products |x Biotechnology. |2 fast |0 (OCoLC)fst01750584 | |
| 700 | 1 | |a Goldstein, Jack, |d 1930- |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Biotechnology of blood. |d Boston : Butterworth-Heinemann, �1991 |z 0750691204 |w (DLC) 91004543 |w (OCoLC)23015898 |
| 830 | 0 | |a Biotechnology series ; |v 19. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780750691208 |z Texto completo |